Account wins

Share this article:

Allergan awarded Pacific Communications the DTC assignment for its severe axillary hyperhidrosis (severe underarm sweating) indication on Botox following a competitive pitch.The campaign, featuring print ads in women's magazines as well as patient brochures and in-office materials, will target young professional women, emphasizing expanded wardrobe possibilities when underarm sweating is brought under control. Pacific Communications already handles professional advertising for the brand, but DTC has traditionally been tasked to big consumer shops. The Costa Mesa, CA, agency first launched Botox as Allergan's in-house shop but was spun off in 1993 and lost the business before regaining professional advertising for the brand in 2004.FDA approved the hyperhidrosis indication in July 2004 on the strength of two clinical trials involving more than 600 adults. One study showed that 91% of adults receiving Botox halved their sweating, while only a third of those receiving a placebo showed similar improvement. Botox (Botulinum Toxin Type A) was first approved in 1989 to treat two eye muscle disorders but has since expanded into numerous other medical and cosmetic indications.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.